Pacific Biosciences Announces $900 Million Investment from SoftBank to Support Growth Initiatives
February 10, 2021 08:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (the “Company”), a leading provider of high-quality, long-read sequencing platforms,...
Pacific Biosciences Grants Equity Incentive Award to New Employee
February 05, 2021 17:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing...
Pacific Biosciences Grants Equity Incentive Award to New Employee
January 29, 2021 16:15 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 29, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing...
Pacific Biosciences of California, Inc. Fourth Quarter 2020 Financial Results Call
January 27, 2021 14:30 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its fourth quarter 2020 financial...
Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform
January 13, 2021 08:02 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced a...
Pacific Biosciences Grants Equity Incentive Awards to New Employees
January 12, 2021 18:26 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality, long read...
Pacific Biosciences of California, Inc. Announces Preliminary Fourth Quarter 2020 Revenue
January 11, 2021 07:45 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (the “Company”) (NASDAQ: PACB), a leading provider of high-quality sequencing platforms, today announced...
Pacific Biosciences Announces Appointments of Mark Van Oene as Chief Operating Officer and Peter Fromen as Chief Commercial Officer
January 08, 2021 08:45 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing solutions, today announced the...
Wellcome Sanger Institute Increases Investment in PacBio Long-Read Sequencing to Support Darwin Tree of Life Research Initiative
January 08, 2021 08:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif ., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that...
Pacific Biosciences Grants Equity Incentive Award to New Employee
December 18, 2020 16:05 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Dec. 18, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing...